MergerJul 29, 2026, 09:06 AM
HeartSciences Files Proxy for Fortitude Merger; Reports FY26 Results
AI Summary
HeartSciences Inc. announced the filing of its preliminary proxy statement for the proposed all-stock merger with Fortitude Mining Holdings, Inc. The company reported no meaningful revenue for its fiscal year ended April 30, 2026, with cash and cash equivalents of $1.7 million and shareholders' equity of $0.2 million. Despite financial challenges, HeartSciences achieved the full commercial launch of its MyoVista Insights platform and submitted its MyoVista wavECG device to the FDA for 510(k) clearance. The merger is presented as a significant value creation opportunity, with Fortitude being a major Zcash mining operator, and includes a proposal for a reverse stock split to maintain Nasdaq listing.
Key Highlights
- Filed preliminary proxy statement for proposed all-stock merger with Fortitude Mining Holdings, Inc.
- Reported no meaningful revenue for Fiscal Year 2026.
- Cash and cash equivalents were approximately $1.7 million as of April 30, 2026.
- Shareholders' equity was $0.2 million as of April 30, 2026.
- Achieved full commercial launch of MyoVista Insights platform.
- Submitted MyoVista wavECG device to FDA for 510(k) clearance.
- Proposed reverse stock split between 1-for-2 and 1-for-5 to meet Nasdaq listing requirements.
- Fortitude mined 72,696 ZEC in H1 2026, representing ~28% of overall ZEC production.
Price Impact
More from HSCS